Safety and Efficacy of amplitude-modulated radiofrequency electromagnetic fields in advanced hepatocellular carcinoma
Research
RF Safe Research Library
Jan 1, 2021
This pooled case series evaluated amplitude-modulated 27.12 MHz RF EMF delivered via the TheraBionic P1 device (3 hours daily) in patients with advanced hepatocellular carcinoma, comparing outcomes to historical controls. The authors report longer median overall survival for Child-Pugh A patients versus comparable…
[Treatment of benign prostatic hyperplasia by radiofrequency (TUNA): a monocentric study of 28 cases treated in ambulatory surgery].
Research
RF Safe Research Library
Jan 1, 2009
This monocentric study evaluated outpatient feasibility and outcomes of radiofrequency transurethral needle ablation (TUNA) for benign prostatic hyperplasia in patients who did not respond to medical therapy. In the outpatient subgroup, urinary symptom scores, quality of life, flow measures, and residual urine…